Investor insights
Sectors invested in
Funding rounds participated in
$35M sweet spot round size
Most of their 37 investments are in rounds between $10M and $100M
Investor type
Basic info
Industry
Sectors
Date founded
2013
Investments made
Ray Therapeutics, Inc. raised $100M on May 16, 2023
Investors: Norwest Venture Partners, Novo Holdings and Wu Capital （双湖资本）
Rona Therapeutics raised $33M on April 7, 2022
Investors: Lilly Asia Ventures, FC CAPITAL, 澜亭资本, CMB International and Wu Capital （双湖资本）
Korro Bio, Inc. raised $116M on January 5, 2022
Investors: MP Healthcare Venture Management Inc, Qiming Venture Partners USA, The Invus Group, Surveyor Capital, Sixty Degree Capital, Monashee Investment Management LLC, Point72 Asset Management and Wu Capital （双湖资本）
RiVAI Technologies raised undisclosed on September 23, 2021
Investors: Baidu.ventures, ZhenFund 真格基金, Hillhouse Capital Management, Northern Light Venture Capital, Lenovo Capital and Incubator Group, ByteDance, Tsing Ventures and Wu Capital （双湖资本）
Undisclosed raised $40M on August 19, 2021
Investors: Wu Capital （双湖资本）
飞榴(上海)信息科技有限公司 raised $31M on May 31, 2021
Investors: SoftBank China Capital, INCE Capital, GGV Capital, ByteDance and Wu Capital （双湖资本）
Laiye raised $50M on April 21, 2021
Investors: PING AN, Lightspeed China Partners, Lightspeed Venture Partners, Sequoia Capital China and Wu Capital （双湖资本）
Gemini Therapeutics raised $95M on February 8, 2021
Investors: Suvretta Capital Management LLC, OrbiMed Advisors, Foresite Capital, Lightstone Ventures, Atlas Venture, Wellington Management, DAFNA Capital Management, LLC and Wu Capital （双湖资本）
Undisclosed raised $305M on December 21, 2020
Investors: Morningside Venture Capital 晨兴资本, Forebright Capital, Tencent and Wu Capital （双湖资本）
Undisclosed raised $35M on November 11, 2020
Investors: Jubilant Biosys Limited, Frazier Healthcare Partners, 5AM Ventures and Wu Capital （双湖资本）